vs
AtriCure, Inc.（ATRC）与OneStream, Inc.（OS）财务数据对比。点击上方公司名可切换其他公司
OneStream, Inc.的季度营收约是AtriCure, Inc.的1.2倍（$163.7M vs $141.2M），OneStream, Inc.净利率更高（0.6% vs 0.1%，领先0.5%），OneStream, Inc.同比增速更快（23.6% vs 14.3%），过去两年OneStream, Inc.的营收复合增速更高（21.8% vs 10.2%）
AtriCure是一家专注于心房颤动及相关心脏病症治疗的医疗设备企业，研发并生产创新外科手术工具与疗法，主要服务北美、欧洲、亚太地区的医院、心脏外科中心及医疗机构，为微创心脏手术提供高效可靠的适配解决方案。
Blue Stream面向美国佛罗里达州科勒尔斯普林斯、韦斯顿两地的居民及商业客户，提供有线电视、有线固话、数字录像服务，以及最高速率达1G的宽带互联网接入服务，深耕当地通信市场，为用户提供稳定可靠的多元通信解决方案。
ATRC vs OS — 直观对比
营收规模更大
OS
是对方的1.2倍
$141.2M
营收增速更快
OS
高出9.3%
14.3%
净利率更高
OS
高出0.5%
0.1%
两年增速更快
OS
近两年复合增速
10.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $141.2M | $163.7M |
| 净利润 | $108.0K | $999.0K |
| 毛利率 | 77.4% | 69.8% |
| 营业利润率 | 23.0% | -3.2% |
| 净利率 | 0.1% | 0.6% |
| 营收同比 | 14.3% | 23.6% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.00 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRCOS
| Q1 26 | $141.2M | — | ||
| Q4 25 | $140.5M | $163.7M | ||
| Q3 25 | $134.3M | $154.3M | ||
| Q2 25 | $136.1M | $147.6M | ||
| Q1 25 | $123.6M | $136.3M | ||
| Q4 24 | $124.3M | $132.5M | ||
| Q3 24 | $115.9M | $129.1M | ||
| Q2 24 | $116.3M | $117.5M |
净利润ATRCOS
| Q1 26 | $108.0K | — | ||
| Q4 25 | — | $999.0K | ||
| Q3 25 | $-267.0K | $-8.8M | ||
| Q2 25 | $-6.2M | $-18.4M | ||
| Q1 25 | $-6.7M | $-24.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-7.9M | $-171.9M | ||
| Q2 24 | $-8.0M | $-7.8M |
毛利率ATRCOS
| Q1 26 | 77.4% | — | ||
| Q4 25 | 75.0% | 69.8% | ||
| Q3 25 | 75.5% | 68.1% | ||
| Q2 25 | 74.5% | 68.6% | ||
| Q1 25 | 74.9% | 68.0% | ||
| Q4 24 | 74.5% | 66.8% | ||
| Q3 24 | 74.9% | 50.1% | ||
| Q2 24 | 74.7% | 68.5% |
营业利润率ATRCOS
| Q1 26 | 23.0% | — | ||
| Q4 25 | 1.8% | -3.2% | ||
| Q3 25 | 0.2% | -11.3% | ||
| Q2 25 | -4.5% | -21.8% | ||
| Q1 25 | -4.8% | -29.3% | ||
| Q4 24 | -11.7% | -35.8% | ||
| Q3 24 | -6.4% | -197.6% | ||
| Q2 24 | -6.2% | -9.8% |
净利率ATRCOS
| Q1 26 | 0.1% | — | ||
| Q4 25 | — | 0.6% | ||
| Q3 25 | -0.2% | -5.7% | ||
| Q2 25 | -4.5% | -12.5% | ||
| Q1 25 | -5.5% | -17.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | -6.8% | -133.1% | ||
| Q2 24 | -6.9% | -6.7% |
每股收益（稀释后）ATRCOS
| Q1 26 | $0.00 | — | ||
| Q4 25 | $0.04 | — | ||
| Q3 25 | $-0.01 | — | ||
| Q2 25 | $-0.13 | — | ||
| Q1 25 | $-0.14 | — | ||
| Q4 24 | $-0.33 | — | ||
| Q3 24 | $-0.17 | $-1.06 | ||
| Q2 24 | $-0.17 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $146.2M | $693.6M |
| 总债务越低越好 | $61.0M | — |
| 股东权益账面价值 | $491.7M | $504.7M |
| 总资产 | $644.0M | $1.0B |
| 负债/权益比越低杠杆越低 | 0.12× | — |
8季度趋势，按日历期对齐
现金及短期投资ATRCOS
| Q1 26 | $146.2M | — | ||
| Q4 25 | $167.4M | $693.6M | ||
| Q3 25 | $147.9M | $653.9M | ||
| Q2 25 | $117.8M | $652.1M | ||
| Q1 25 | $99.9M | $593.9M | ||
| Q4 24 | $122.7M | $544.2M | ||
| Q3 24 | $130.3M | $495.5M | ||
| Q2 24 | $114.0M | $140.5M |
总债务ATRCOS
| Q1 26 | $61.0M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $61.9M | — | ||
| Q2 25 | $61.9M | — | ||
| Q1 25 | $61.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $61.9M | — | ||
| Q2 24 | $61.9M | — |
股东权益ATRCOS
| Q1 26 | $491.7M | — | ||
| Q4 25 | $491.9M | $504.7M | ||
| Q3 25 | $476.5M | $472.1M | ||
| Q2 25 | $464.5M | $458.2M | ||
| Q1 25 | $454.6M | $412.9M | ||
| Q4 24 | $461.0M | $386.2M | ||
| Q3 24 | $465.0M | $458.2M | ||
| Q2 24 | $462.1M | $97.5M |
总资产ATRCOS
| Q1 26 | $644.0M | — | ||
| Q4 25 | $654.2M | $1.0B | ||
| Q3 25 | $635.4M | $949.4M | ||
| Q2 25 | $608.8M | $910.5M | ||
| Q1 25 | $591.6M | $867.3M | ||
| Q4 24 | $609.3M | $823.2M | ||
| Q3 24 | $615.1M | $750.1M | ||
| Q2 24 | $597.3M | $379.7M |
负债/权益比ATRCOS
| Q1 26 | 0.12× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.13× | — | ||
| Q2 25 | 0.13× | — | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.13× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.8M |
| 自由现金流经营现金流 - 资本支出 | — | $25.6M |
| 自由现金流率自由现金流/营收 | — | 15.7% |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | — | 25.79× |
| 过去12个月自由现金流最近4个季度 | — | $95.6M |
8季度趋势，按日历期对齐
经营现金流ATRCOS
| Q1 26 | — | — | ||
| Q4 25 | $20.0M | $25.8M | ||
| Q3 25 | $26.7M | $5.0M | ||
| Q2 25 | $21.6M | $29.7M | ||
| Q1 25 | $-11.0M | $36.2M | ||
| Q4 24 | $5.8M | — | ||
| Q3 24 | $20.0M | $2.4M | ||
| Q2 24 | $7.4M | $8.1M |
自由现金流ATRCOS
| Q1 26 | — | — | ||
| Q4 25 | $18.4M | $25.6M | ||
| Q3 25 | $24.1M | $4.8M | ||
| Q2 25 | $19.0M | $29.4M | ||
| Q1 25 | $-13.2M | $35.8M | ||
| Q4 24 | $3.1M | — | ||
| Q3 24 | $16.4M | $1.3M | ||
| Q2 24 | $5.0M | $7.7M |
自由现金流率ATRCOS
| Q1 26 | — | — | ||
| Q4 25 | 13.1% | 15.7% | ||
| Q3 25 | 18.0% | 3.1% | ||
| Q2 25 | 13.9% | 19.9% | ||
| Q1 25 | -10.7% | 26.3% | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 14.1% | 1.0% | ||
| Q2 24 | 4.3% | 6.6% |
资本支出强度ATRCOS
| Q1 26 | — | — | ||
| Q4 25 | 1.1% | 0.1% | ||
| Q3 25 | 1.9% | 0.1% | ||
| Q2 25 | 2.0% | 0.2% | ||
| Q1 25 | 1.8% | 0.3% | ||
| Q4 24 | 2.2% | — | ||
| Q3 24 | 3.1% | 0.8% | ||
| Q2 24 | 2.1% | 0.3% |
现金转化率ATRCOS
| Q1 26 | — | — | ||
| Q4 25 | — | 25.79× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATRC
| Appendage management | $48.4M | 34% |
| Open ablation | $39.1M | 28% |
| Other | $25.0M | 18% |
| Pain management | $22.4M | 16% |
| Minimally invasive ablation | $6.4M | 5% |
OS
| Subscription And Circulation | $150.3M | 92% |
| Professional Services And Other | $9.4M | 6% |
| License | $4.0M | 2% |
